Active Ingredient: TERBINAFINE
(Hérité de TERBINAFINE BAILLEUL 250 mg) A 2014 narrative review identified no studies reporting a QT prolongation risk with Terbinafine
https://doi.org/10.1016/S0009-9236(96)80005-1, https://doi.org/10.1007/s12281-014-0183-0